BB Biotech Future Growth
Future criteria checks 0/6
BB Biotech's revenue and earnings are forecast to decline at 51.7% and 43.2% per annum respectively while EPS is expected to decline by 16.5% per annum.
Key information
-43.2%
Earnings growth rate
-16.5%
EPS growth rate
Capital Markets earnings growth | -14.7% |
Revenue growth rate | -51.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 19 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 101 | 72 | 232 | 232 | 2 |
12/31/2024 | 190 | 152 | 193 | 193 | 1 |
3/31/2024 | 271 | 308 | 86 | 86 | N/A |
12/31/2023 | 0 | -207 | 218 | 218 | N/A |
9/30/2023 | 0 | -351 | 159 | 159 | N/A |
6/30/2023 | 0 | -92 | 185 | 185 | N/A |
3/31/2023 | 0 | -312 | 213 | 213 | N/A |
12/31/2022 | 0 | -358 | 231 | 231 | N/A |
9/30/2022 | -187 | -869 | 190 | 190 | N/A |
6/30/2022 | -380 | -1,287 | 213 | 213 | N/A |
3/31/2022 | -236 | -926 | 226 | 226 | N/A |
12/31/2021 | N/A | -405 | -95 | -95 | N/A |
9/30/2021 | 867 | 806 | 190 | 190 | N/A |
6/30/2021 | 677 | 619 | 71 | 71 | N/A |
3/31/2021 | 1,724 | 1,670 | 180 | 180 | N/A |
12/31/2020 | 742 | 691 | 262 | 262 | N/A |
9/30/2020 | 581 | 532 | 291 | 291 | N/A |
6/30/2020 | 964 | 545 | 385 | 385 | N/A |
3/31/2020 | -598 | -970 | 231 | 231 | N/A |
12/31/2019 | 728 | 677 | 215 | 215 | N/A |
9/30/2019 | -43 | -471 | 155 | 155 | N/A |
6/30/2019 | 211 | 153 | 140 | 140 | N/A |
3/31/2019 | 582 | 390 | 95 | 95 | N/A |
12/31/2018 | 5 | -471 | 108 | 108 | N/A |
9/30/2018 | 114 | 16 | -128 | -128 | N/A |
6/30/2018 | 234 | 139 | -170 | -170 | N/A |
3/31/2018 | 347 | 341 | 189 | 189 | N/A |
12/31/2017 | 730 | 688 | N/A | 263 | N/A |
9/30/2017 | 875 | 819 | N/A | 347 | N/A |
6/30/2017 | 901 | 846 | N/A | 494 | N/A |
3/31/2017 | 433 | 778 | N/A | 189 | N/A |
12/31/2016 | 9 | -802 | N/A | 115 | N/A |
9/30/2016 | 530 | -266 | N/A | 30 | N/A |
6/30/2016 | 130 | -1,234 | N/A | -282 | N/A |
3/31/2016 | 265 | -932 | N/A | -146 | N/A |
12/31/2015 | 697 | 653 | N/A | 53 | N/A |
9/30/2015 | 908 | 868 | N/A | 244 | N/A |
6/30/2015 | 1,397 | 1,926 | N/A | 457 | N/A |
3/31/2015 | 1,818 | 1,784 | N/A | 310 | N/A |
12/31/2014 | 1,498 | 1,470 | N/A | 122 | N/A |
9/30/2014 | 867 | 844 | N/A | 87 | N/A |
6/30/2014 | 722 | 700 | N/A | 30 | N/A |
3/31/2014 | 660 | 639 | N/A | 49 | N/A |
12/31/2013 | 950 | 932 | N/A | 117 | N/A |
9/30/2013 | 719 | 697 | N/A | 65 | N/A |
6/30/2013 | 529 | 507 | N/A | 126 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIOEE's earnings are forecast to decline over the next 3 years (-43.2% per year).
Earnings vs Market: BIOEE's earnings are forecast to decline over the next 3 years (-43.2% per year).
High Growth Earnings: BIOEE's earnings are forecast to decline over the next 3 years.
Revenue vs Market: BIOEE's revenue is expected to decline over the next 3 years (-51.7% per year).
High Growth Revenue: BIOEE's revenue is forecast to decline over the next 3 years (-51.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BIOEE's Return on Equity is forecast to be high in 3 years time